Package 50742-484-01

{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "4bcd8cc3-e644-4daa-89ba-9b302cb48dee", "openfda": {"nui": ["N0000175604", "N0000175075"], "upc": ["0350742484010"], "unii": ["69G8BD63PP"], "rxcui": ["402243"], "spl_set_id": ["c9bf8425-afa5-4171-b114-d83acb6d526d"], "pharm_class_epc": ["Proteasome Inhibitor [EPC]"], "pharm_class_moa": ["Proteasome Inhibitors [MoA]"], "manufacturer_name": ["Ingenus Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (50742-484-01)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL", "package_ndc": "50742-484-01", "marketing_end_date": "20260430", "marketing_start_date": "20220501"}], "brand_name": "Bortezomib", "product_id": "50742-484_4bcd8cc3-e644-4daa-89ba-9b302cb48dee", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Proteasome Inhibitor [EPC]", "Proteasome Inhibitors [MoA]"], "product_ndc": "50742-484", "generic_name": "Bortezomib", "labeler_name": "Ingenus Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bortezomib", "active_ingredients": [{"name": "BORTEZOMIB", "strength": "3.5 mg/1"}], "application_number": "ANDA210824", "marketing_category": "ANDA", "marketing_end_date": "20260430", "marketing_start_date": "20220501"}